期刊文献+

冠心病患者全血中miR-126表达的临床意义 被引量:3

The expression of microRNA-126 in different types of coronary heart disease
下载PDF
导出
摘要 目的探讨微小RNA(miR-126)在不同类型冠心病患者中的表达情况,为冠心病早期诊断、治疗及治疗后检测提供实验依据。方法将实验分成健康对照组(n=6)及冠心病组(n=36),对冠心病组(分为稳定性心绞痛组,不稳定性心绞痛组,非ST段抬高性心肌梗死组,ST段抬高性心肌梗死组,每组9例)接受经皮冠状动脉介入治疗(PCI)术前,术后第1天,术后第5天等时间点的观察。应用实时荧光定量PCR(qRT-qPCR)技术检测确诊为不同类型冠心病患者术前、术后全血标本中miR-126的表达量。结果 qRT-qPCR结果显示:①健康对照组、稳定性心绞痛组、不稳定性心绞痛组3组miR-126的表达量无显著性差异,但在急性心肌梗死组(包括非ST段抬高性组、ST段抬高性组)患者中miR-126的表达量与上述三组明显减少,有显著性差异(P<0.05)。②miR-126在不同时间水平有显著性差异(P<0.05),ST段抬高或非ST段抬高型心肌梗死的miR-126的表达量术前明显低,术后随观察时间延长逐渐增加。③在不同时间时不同分组之间miR-126的表达量存在显著的交互效应(P<0.05)。结论 miR-126在急性心肌梗死患者中及冠心病各组术前、术后的表达量明显不同,这为miR-126应用于不同类型冠心病诊断及术后疗效判断提供实验依据。 Objective To investigate the miR - 126 expression in different types of patients with coronary heart disease detection, to provide experimental evidence for the early diagnosis of coronary heart disease, the treatment and after treatment. Methods Samples were divided into the control group (n =6) and the experimental group (patients with coronary heart disease, n =36). The experimental groups were treated with percutaneous coronary intervention treatment (PCI). These samples were observed preoperative and postoperative day 1, five days after same point in time. The expression of miR - 126 of whole blood samples in the different patients ( stable angina, unstable angina, ST - segment elevation myocardial infarction, non - ST - segment elevation myocardial infarction, each group 9 case) was detected by the application of real - time fluorescence quantitative PCR (qRT- qPCR). Results ①The expression of miR - 126 between the three groups (healthy control, stable angina, unstable angina) was not significantly different, but it is significantly different and significantly reduced in the acute myocardial infarction group (in- cluding non - ST - segment elevation group, ST elevation group). ②There were significant differences ( P 〈0.05) of miR - 126 levels at different times. The expression level of miR - 126 in patients with ST - segment or non - ST - segment elevation myocardial infarction before operation was significantly lower than the that of after treatment. The expression gradually increased with the observation time. ③There is a significant interaction about the expression level of miR - 126 between time and different types of coronary heart disease ( P 〈0.05). The trend of the them was significantly different. Conclusion The miR - 126 expression was significantly different in the different types of coronary heart disease and patients with preoperative and postoperative. It may be provide experimental basis to the diagnosis of coronary heart disease and postoperative by the detection of miR - 126.
出处 《临床和实验医学杂志》 2014年第11期869-872,共4页 Journal of Clinical and Experimental Medicine
基金 广东省科技计划项目 基金编号:2010B031500030
关键词 MIR-126 冠心病 QRT-PCR MiR - 126 Coronary heart disease qRT-PCR
  • 相关文献

参考文献13

  • 1Camussi G, Deregibus MC, Bruno S, et al. Exosomes/microvesicles as a mechanism of cell - to - cell communication [ J ]. Kidney Int, 2010, 78(9) :838 -848.
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2049
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2117
  • 4Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction[J]. Eur Heart J, 2007,28(20) :2525 -2538.
  • 5Small EM, Frost RJ, Olson EN. biicmRNAs add a new dimension to cardiovascular disease[ J]. Circulation, 2010,121 (8) : 1022 - 1032.
  • 6Bostjancic E, Zidar N, Glavac D. MicroRNA microarray expression profiling in human myocardial infarction[ J]. Dis Markers, 2009,27(6) : 255 - 268.
  • 7Terentyev D, Belevych AE, Terentyeva R, et al. miR - 1 overexprcssion enhances Ca(2 + ) release and promotes cardiac arrhythmogenesis by targeting PP2Aregulatory subunit B56alpha and causing CaMKII - dependent hyperphosphorylation of RyR2 [ J ]. Circ Res, 2009, 104 (4) :514 -521.
  • 8Ai J, Zhang R, Li Y, et al. Circulating microRNA - 1 as a potential novel biomarker for acute myocardial infarction [ J ]. Biochem Biophys Res Commun, 2010,391 ( 1 ) :73 - 77.
  • 9Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA : a novel potential biomarker for early diagnosis of acute myocardial infarction in humans[J]. Eur Heart J, 2010,31(6) :659 -666.
  • 10Meder B, Keller A, Vogel B, et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction [ J ]. Basic Res Cardiol, 2011,106( 1 ) :13 -23.

二级参考文献72

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 3Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 4Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 5Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 6O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 7Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 8Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 9Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
  • 10Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.

共引文献3919

同被引文献41

  • 1Adam M Noyes,Kirandeep Dua,Ramprakash Devadoss,Lovely Chhabra.Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease[J].World Journal of Diabetes,2014,5(6):868-876. 被引量:8
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2049
  • 3FUKUSHIMA Y, NAKANISHI M, NONOGI H, et al. Assessment of plasma miRNAs in congestive heart failure [ J ]. Cite J, 2011, 75(2): 336-340.
  • 4YE P, LIU J, HE F Y, et al. Hypoxia-induced deregulation of miR-126 and its regulative effect on VEGF and MMP-9 expression [J]. Int J Med Sei, 2014, 11(1) : 17-23.
  • 5FICHTLSCHERER S, ZEIHER A M, DIMMELER S. Circulating mieroRNAs : biomarkers or mediators of cardiovascular disease [ J ]. Arterioscler Thromb Vase Biol, 2011, 31 ( 11 ) : 2383-2390.
  • 6ZOU J, LI W Q, LI Q, et al. Two functional microrna-126s repress a novel target gene p21-activated kinase 1 to regulate vascular integrity in Zebrafish [J]. Circ Res, 2011, 108 (2) : 201-209.
  • 7SMALL E M, FROST R J, OLSON E N. MicroRNAs add a new dimension to cardiovascular disease [J]. Circulation, 2010, 121(8) : 1022-1032.
  • 8CAMUSSI G, DEREGIBUS M C, BRUNO S, et al . Exosomes/microvesicles as a mechanism of cell-to-cell communication [J]. Kidney Int, 2010, 78(9) : 838-848.
  • 9SUN C, ALKHOURY K, WANG Y I, et al. IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal [J]. Circ Res, 2012, 111(8): 1054-1064.
  • 10LONG G W, WANG F, DUAN Q, et al. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction[J]. Int J Biol Sci, 2012, 8(6) : 811-818.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部